KPC Pharmaceuticals Inc (600422) — Cash Flow Quality Index
KPC Pharmaceuticals Inc (600422) has a Cash Flow Quality Index of -0.23x as of September 2025. Operating cash flow of CN¥-16.66 Million is below net income of CN¥71.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore KPC Pharmaceuticals Inc (600422) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
KPC Pharmaceuticals Inc Cash Flow Quality Index (1999–2024)
Historical Cash Flow Quality Index for KPC Pharmaceuticals Inc across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KPC Pharmaceuticals Inc (600422) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for KPC Pharmaceuticals Inc (1999–2024)
Year-by-year earnings quality comparison for KPC Pharmaceuticals Inc. For live market cap and the full company financial profile, see KPC Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.08x | CN¥808.07 Million | CN¥751.22 Million | ▲ +34.3% |
| 2023 | 0.80x | CN¥356.08 Million | CN¥444.68 Million | ▲ +21.6% |
| 2022 | 0.66x | CN¥253.90 Million | CN¥385.46 Million | ▲ +34.3% |
| 2021 | 0.49x | CN¥251.63 Million | CN¥513.21 Million | ▼ -44.7% |
| 2020 | 0.89x | CN¥409.94 Million | CN¥462.18 Million | ▼ -3.4% |
| 2019 | 0.92x | CN¥429.50 Million | CN¥467.76 Million | ▼ -10.9% |
| 2018 | 1.03x | CN¥352.07 Million | CN¥341.69 Million | ▲ +42.4% |
| 2017 | 0.72x | CN¥242.53 Million | CN¥335.29 Million | ▼ -4.8% |
| 2016 | 0.76x | CN¥311.16 Million | CN¥409.52 Million | ▼ -31.2% |
| 2015 | 1.11x | CN¥476.62 Million | CN¥431.32 Million | ▼ -10.3% |
| 2014 | 1.23x | CN¥379.13 Million | CN¥307.70 Million | ▲ +20.0% |
| 2013 | 1.03x | CN¥241.97 Million | CN¥235.64 Million | ▼ -3.2% |
| 2012 | 1.06x | CN¥213.33 Million | CN¥201.18 Million | ▲ +10.0% |
| 2011 | 0.96x | CN¥140.24 Million | CN¥145.46 Million | ▲ +4.8% |
| 2010 | 0.92x | CN¥90.82 Million | CN¥98.68 Million | ▼ -52.1% |
| 2009 | 1.92x | CN¥128.57 Million | CN¥66.95 Million | ▼ -24.1% |
| 2008 | 2.53x | CN¥91.59 Million | CN¥36.21 Million | ▼ -39.8% |
| 2007 | 4.20x | CN¥130.06 Million | CN¥30.95 Million | ▲ +24.5% |
| 2006 | 3.38x | CN¥61.25 Million | CN¥18.15 Million | ▲ +11943.3% |
| 2004 | -0.03x | CN¥-2.78 Million | CN¥97.47 Million | ▼ -103.8% |
| 2003 | 0.76x | CN¥61.23 Million | CN¥80.74 Million | ▲ +131.6% |
| 2002 | 0.33x | CN¥17.38 Million | CN¥53.09 Million | ▼ -78.0% |
| 2001 | 1.49x | CN¥67.07 Million | CN¥45.03 Million | ▲ +42.2% |
| 2000 | 1.05x | CN¥47.76 Million | CN¥45.58 Million | ▼ -35.6% |
| 1999 | 1.63x | CN¥60.24 Million | CN¥37.01 Million | — |